Suppr超能文献

儿童重度和极重度哮喘

Difficult and Severe Asthma in Children.

作者信息

Porcaro Federica, Ullmann Nicola, Allegorico Annalisa, Di Marco Antonio, Cutrera Renato

机构信息

Pediatric Pulmonology & Respiratory Intermediate Care Unit, Sleep and Long-Term Ventilation Unit, Academic Department of Pediatrics, and Genetic Research Area, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.

出版信息

Children (Basel). 2020 Dec 10;7(12):286. doi: 10.3390/children7120286.

Abstract

Asthma is the most frequent chronic inflammatory disease of the lower airways affecting children, and it can still be considered a challenge for pediatricians. Although most asthmatic patients are symptom-free with standard treatments, a small percentage of them suffer from uncontrolled persistent asthma. In these children, a multidisciplinary systematic assessment, including comorbidities, treatment-related issues, environmental exposures, and psychosocial factors is needed. The identification of modifiable factors is important to differentiate children with difficult asthma from those with true severe therapy-resistant asthma. Early intervention on modifiable factors for children with difficult asthma allows for better control of asthma without the need for invasive investigation and further escalation of treatment. Otherwise, addressing a correct diagnosis of true severe therapy-resistant asthma avoids diagnostic and therapeutic delays, allowing patients to benefit from using new and advanced biological therapies.

摘要

哮喘是影响儿童的最常见的下呼吸道慢性炎症性疾病,对儿科医生来说仍是一项挑战。尽管大多数哮喘患者通过标准治疗无症状,但仍有一小部分患者患有未得到控制的持续性哮喘。对于这些儿童,需要进行多学科系统评估,包括合并症、治疗相关问题、环境暴露和社会心理因素。识别可改变因素对于区分难治性哮喘儿童和真正的重度治疗抵抗性哮喘儿童很重要。对难治性哮喘儿童的可改变因素进行早期干预,可在无需进行侵入性检查和进一步强化治疗的情况下更好地控制哮喘。否则,正确诊断真正的重度治疗抵抗性哮喘可避免诊断和治疗延误,使患者能够受益于使用新的先进生物疗法。

相似文献

1
Difficult and Severe Asthma in Children.
Children (Basel). 2020 Dec 10;7(12):286. doi: 10.3390/children7120286.
2
Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.
Front Pediatr. 2018 Jun 19;6:170. doi: 10.3389/fped.2018.00170. eCollection 2018.
3
Severe uncontrolled asthma in children: practical approach on diagnosis and management.
Minerva Pediatr. 2020 Jun;72(3):196-205. doi: 10.23736/S0026-4946.20.05818-1. Epub 2020 Feb 27.
4
Managing the pediatric patient with refractory asthma: a multidisciplinary approach.
J Asthma Allergy. 2017 Apr 20;10:123-130. doi: 10.2147/JAA.S129159. eCollection 2017.
5
The dark side of the moon: severe therapy-resistant asthma in children.
Monaldi Arch Chest Dis. 2012 Jun;77(2):83-93. doi: 10.4081/monaldi.2012.156.
6
The management of severe asthma in 2020.
Biochem Pharmacol. 2020 Sep;179:114112. doi: 10.1016/j.bcp.2020.114112. Epub 2020 Jun 27.
7
How to manage a child with difficult asthma?
Expert Rev Respir Med. 2016 Aug;10(8):873-9. doi: 10.1080/17476348.2016.1191355. Epub 2016 Jun 2.
8
Severe Asthma: Challenges and Pitfalls in Management.
Indian J Pediatr. 2018 Sep;85(9):763-772. doi: 10.1007/s12098-018-2686-0. Epub 2018 May 7.
9
A Practical Approach to Severe Asthma in Children.
Ann Am Thorac Soc. 2018 Apr;15(4):399-408. doi: 10.1513/AnnalsATS.201708-637FR.
10
Severe asthma in children: Evaluation and management.
Allergol Int. 2019 Apr;68(2):150-157. doi: 10.1016/j.alit.2018.11.007. Epub 2019 Jan 14.

引用本文的文献

1
Progress in diagnosis and treatment of difficult-to-treat asthma in children.
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231213637. doi: 10.1177/17534666231213637.
3
Effects of Allergen Exposure and Environmental Risk Factors in Schools on Childhood Asthma.
Curr Allergy Asthma Rep. 2023 Oct;23(10):613-620. doi: 10.1007/s11882-023-01108-8. Epub 2023 Aug 31.
4
T2-Low Asthma: A Discussed but Still Orphan Disease.
Biomedicines. 2023 Apr 20;11(4):1226. doi: 10.3390/biomedicines11041226.
5
Editorial: Difficult and severe asthma in children, volume II.
Front Pediatr. 2023 Mar 16;11:1158309. doi: 10.3389/fped.2023.1158309. eCollection 2023.
6
Editorial: Insights in pediatric pulmonology 2021.
Front Pediatr. 2022 Nov 23;10:1093793. doi: 10.3389/fped.2022.1093793. eCollection 2022.
7
Implementation of Coach McLungs into primary care using a cluster randomized stepped wedge trial design.
BMC Med Inform Decis Mak. 2022 Nov 4;22(1):285. doi: 10.1186/s12911-022-02030-1.
8
Respiratory Symptoms, Allergies, and Environmental Exposures in Children with and without Asthma.
Int J Environ Res Public Health. 2022 Sep 6;19(18):11180. doi: 10.3390/ijerph191811180.
9
Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma.
Front Pediatr. 2022 Jul 19;10:896865. doi: 10.3389/fped.2022.896865. eCollection 2022.
10
Severe Pediatric Asthma Therapy: Mepolizumab.
Front Pediatr. 2022 Jul 1;10:920066. doi: 10.3389/fped.2022.920066. eCollection 2022.

本文引用的文献

1
Advances and recent developments in asthma in 2020.
Allergy. 2020 Dec;75(12):3124-3146. doi: 10.1111/all.14607. Epub 2020 Oct 16.
2
Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
World Allergy Organ J. 2020 Sep 18;13(9):100462. doi: 10.1016/j.waojou.2020.100462. eCollection 2020 Sep.
3
Response to mepolizumab treatment is sustained across 4-weekly dosing periods.
ERJ Open Res. 2020 Sep 14;6(3). doi: 10.1183/23120541.00068-2020. eCollection 2020 Jul.
4
Effectiveness of mepolizumab therapy in patients with severe eosinophilic asthma: Austrian real-life data.
Pulm Pharmacol Ther. 2020 Oct;64:101946. doi: 10.1016/j.pupt.2020.101946. Epub 2020 Sep 17.
5
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis.
Eur Respir J. 2020 Oct 15;56(4). doi: 10.1183/13993003.00151-2020. Print 2020 Oct.
7
EAACI Biologicals Guidelines-Recommendations for severe asthma.
Allergy. 2021 Jan;76(1):14-44. doi: 10.1111/all.14425. Epub 2020 Aug 10.
8
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives.
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2222-2233. doi: 10.1016/j.jaip.2020.02.036. Epub 2020 Mar 12.
9
Dupilumab to Treat Type 2 Inflammatory Diseases in Children and Adolescents.
Paediatr Drugs. 2020 Jun;22(3):295-310. doi: 10.1007/s40272-020-00387-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验